Deal Library / Pharma BD Deal Intelligence

Watson Pharmaceuticals (Actavis Inc.) — Pharma Deals

The Pharma Closeout tracks 9 deals, $13.2B in disclosed deal value, 9 with a post-close Outcome Score for Watson Pharmaceuticals (Actavis Inc.).

Median Critic Score: 79 · Median Outcome Score: 65

All 9 deals

Watson Pharmaceuticals (Actavis Inc.) / Actavis plc — 2012 · $5.9B · Worked — the deal delivered on its rationale.
Watson Pharmaceuticals (Actavis Inc.) / Arrow Group — 2009 · $1.8B · Worked — the deal delivered on its rationale.
Watson Pharmaceuticals (Actavis Inc.) / Amarin Development AB (Amarin Corp subsidiary) — 2003 · $150M · Largely worked — most objectives met.
Watson Pharmaceuticals (Actavis Inc.) / Andrx Corporation — 2006 · $1.9B · Largely worked — most objectives met.
Watson Pharmaceuticals (Actavis Inc.) / Schein Pharmaceutical Inc. — 2000 · $674M · Largely worked — most objectives met.
Watson Pharmaceuticals (Actavis Inc.) / Eden Biodesign Limited — 2010 · $15M · Largely worked — most objectives met.
Watson Pharmaceuticals (Actavis Inc.) / Andrx Corporation — 2007 · $1.9B · Largely worked — most objectives met.
Watson Pharmaceuticals (Actavis Inc.) / Specifar Pharmaceuticals S.A. — 2011 · $562M · Underwhelmed — fell short of the thesis.
Watson Pharmaceuticals (Actavis Inc.) / Uteron Pharma SA — 2013 · $305M · Did not work — the deal failed to deliver.